Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Possible catalysts...please add your thoughts...I’ll start
View:
Post by Marky1 on Feb 12, 2021 2:17pm

Possible catalysts...please add your thoughts...I’ll start

1) sale of Citagenix resulting in a Pure Play company...As said by Mugsy some time ago..We've grown and don't need it anymore
Comment by Marky1 on Feb 12, 2021 2:30pm
2) end of P2 meeting with the FDA....this could come at any time! Hopefully very soon 3) More deals, Japan, Europe, South America....to bring more cash in to fund P3 testing and more 4) Fast track of 352 5).  IND for 346, 352 So many catalysts
Comment by Marky1 on Feb 12, 2021 3:03pm
And the crme of the crme....Dr.Haut puts together a deal like AskBio.....to buy us out...50$ a share or a 2B$ CDN market cap...Going to happen! Patience will be rewarded!
Comment by WalkOverTheStrt on Feb 12, 2021 10:13pm
$2B CAD seems a tad light, mgmt won't sell imo for less than $3.5 / $4b USD, with patent life (2032) and ability to generate $4b peak sales.... not seeing them be desparte 
Comment by Marky1 on Feb 12, 2021 10:26pm
I agree with you Walk...At 3.5B USD. That's 88$ a share
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities